Cargando…
Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer
Background and study aims: The HER2 status of small endoscopic biopsies is important for predicting the eligibility of patients with metastatic HER2-positive gastric cancer or gastro-esophageal junction (GEJ) cancer for anti-HER2 therapy approved by the U.S. Food and Drug Administration. The aim of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
© Georg Thieme Verlag KG
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477016/ https://www.ncbi.nlm.nih.gov/pubmed/26135662 http://dx.doi.org/10.1055/s-0034-1391359 |